JT King is a Registered Respiratory Therapist with extensive experience in hospital settings, where he conducts Pulmonary Function Tests (PFTs) and treats patients, including many with post-COVID chronic cough (long COVID).

 

In 2019, amid the emergence of COVID-19, he invented Manukahol—an at-home nebulized inhalation therapy—and later refined it into Manukahol Mentholated by adding menthol for enhanced cough relief.

 

Frustrated by the lack of effective home treatments for viral infections from major pharmaceutical companies, JT designed it as a simple, targeted "virus killer" for nasal-swab-detectable infections, emphasizing real science and common sense. The product is patent-pending and positioned as the first and only inhalation therapy specifically for home use.